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Neuroepithelial cell competition 
triggers loss of cellular 
juvenescence
Faidruz Azura Jam1,4, Takao Morimune1,2,4, Atsushi Tsukamura1,2,4, Ayami Tano1, 
Yuya Tanaka1, Yasuhiro Mori3, Takefumi Yamamoto3, Masaki Nishimura1, Ikuo Tooyama1 & 
Masaki Mori1*
Cell competition is a cell–cell interaction mechanism which maintains tissue homeostasis through 
selective elimination of unfit cells. During early brain development, cells are eliminated through 
apoptosis. How cells are selected to undergo elimination remains unclear. Here we aimed to identify 
a role for cell competition in the elimination of suboptimal cells using an in vitro neuroepithelial 
model. Cell competition was observed when neural progenitor HypoE-N1 cells expressing  RASV12 
were surrounded by normal cells in the co-culture. The elimination through apoptosis was observed 
by cellular changes of  RASV12 cells with rounding/fragmented morphology, by SYTOX blue-positivity, 
and by expression of apoptotic markers active caspase-3 and cleaved PARP. In this model, expression 
of juvenility-associated genes Srsf7 and Ezh2 were suppressed under cell-competitive conditions. 
Srsf7 depletion led to loss of cellular juvenescence characterized by suppression of Ezh2, cell growth 
impairment and enhancement of senescence-associated proteins. The cell bodies of eliminated cells 
were engulfed by the surrounding cells through phagocytosis. Our data indicates that neuroepithelial 
cell competition may have an important role for maintaining homeostasis in the neuroepithelium by 
eliminating suboptimal cells through loss of cellular juvenescence.
One of the fundamental questions in developmental biology is whether there are mechanisms that can detect 
aberrant, defective, or mutant cells that compromise their capability to contribute to development. Occurrence 
of endogenous apoptosis is increased in early development, around embryonic day E6.51, and this implies cell 
competition might contribute to selection of fitter cells and the elimination of unwanted cells. Cell competition 
has been reported in mouse  embryos2 during epiblast  formation3, in various organs such as  epidermis4,  heart5 
and  pancreas3, but is less understood in the nervous system.
Programmed cell death (PCD) has a significant functional role in nervous system development with apop-
tosis being the major form of  PCD6. Senescence-undergoing cells are present in early developing embryos in 
mice,  human7 and Xenopus8. As defective, senescent and unwanted cells need to be eliminated, a quality control 
mechanism to ensure proper tissue growth and homeostasis must exist. However, the molecular mechanisms 
underlying this process are unknown.
Cell competition is a conserved cell-eliminating mechanism for tissue homeostasis  maintenance9, quality 
 control10 and as a tumor suppressive  mechanism11. The phenomenon was discovered more than 40 years ago in 
the wing disc of Drosophila melanogaster, in which Minutes mutants that exhibit defective protein synthesis were 
eliminated actively during development and disappeared from the adult body. This mechanism is evolutionarily 
 conserved12,13.
Determination of cell fate between winner or loser is a non-cell autonomous property of a cell, and it is elicited 
by cellular interactions with neighbouring  cells14. Cell fitness is an unquantifiable concept referring to quality of 
a cell, for example growth rate, differential activation of cell damage pathways and metabolic activity, although 
recent works have identified the relevance of several fitness markers such as for flower15 or Sparc16. Cell competi-
tion usually requires contact or close  proximity14, as in Minute-mediated cell  competition17, to provoke fitness 
comparison. Among important hallmarks of cell competition are context dependency, which are triggered by a 
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local difference in cellular growth or metabolism, proliferation of winner cells stimulated by loss of loser cells, 
and short-range effects which are stronger at the interface between loser and winner  cells18. Mechanisms for the 
loser-cell elimination are through  apoptosis19,  engulfment17, apical  extrusion20 and basal  extrusion21.
Well-characterized inducers of cell competition include minute22, Bone morphogenetic proteins (BMPs)1, 
Myc2, and Ras20,23. The discovery of HRAS (Harvey rat sarcoma virus) in 1964 was isolated from the passage 
of Moloney type-C virus in  rats24. High expression of activated HRAS oncogene has been proposed to induce 
 senescence25. An oncogene-induced senescence (OIS) has been reported by induction of an oncogenic form of 
RAS in normal human  fibroblasts26.
Cellular juvenescence is characterized by the ability of cells to grow, differentiate and resist premature 
 senescence27.  We previously identified juvenility-associated genes (JAGs) expressed in  brain28, cardiomyocytes 
and  hepatocytes29. JAGs are genes selectively highly expressed in juvenile cells. Srsf7, Serine-Arginine-rich family 
of pre-mRNA splicing factors, which constitutes a part of the spliceosome, is one of the  JAGs29.
In this communication, to investigate the role of cell competition in the developing brain, we have established 
an in vitro model system. In mice, formation of a neural plate begins at E7.5. Neural plate is an earliest indication 
of neural development. At this stage, cephalization begins with the presence of enlarged head folds and forma-
tion of neural plate from the ectoderm, which converts into neuroectoderm. Based on this developmental stage, 
we have established a heterogeneous neuroepithelial model in which neural progenitor HypoE-N1 cells were 
cultured as a monolayer. Heterogeneity was introduced by induction of  RASV12 in a small proportion of the cells. 
We investigated the molecular mechanisms in neuroepithelial cell competition by which juvenescence-losing 
cells are sensed and eliminated from the neuroepithelium. In this study, we clarify a role of cell competition as 
a quality-control mechanism to orchestrate homeostasis in the brain.
Results
Establishment of the neuroepithelial cell competition model. To investigate the phenomenon 
of cell competition in the developing mammalian central nervous system, we established a cellular model for 
neuroepithelium using HypoE-N1 cells, a neural progenitor cell line derived from mouse fetal hypothalamus. 
We performed conditioned medium assays and indirect co-culture assays to exclude the possibility of indi-
rect effects. We confirmed that neuroepithelial cell competition requires direct cell–cell contact, and was not 
mediated by soluble factors produced during competitive co-culture (Supplementary Fig. S1). In this system, 
we co-cultured normal HypoE-N1 cells with doxycycline-inducible  RASV12-EGFP-transfected HypoE-N1 cells 
(hereinafter referred to as  RASV12 cells) at a 100:1 ratio to create competitive conditions. For the non-competitive 
condition, we co-cultured  RASV12 cells with  RASV12 cells labeled with the fluorescent dye CMTPX (Fig. 1a). The 
expression of  RASV12 upon doxycycline treatment was validated by western blot analysis.  RASV12 was expressed 
stably up to 72 h with doxycycline treatment (Fig. 1b). SYTOX blue staining showed  RASV12 cells in a competi-
tive condition are positive, indicating they are dying (Fig. 1c). The percentage of SYTOX blue positive in  RASV12 
cells in competitive condition were significantly higher compared to normal cells. However, in the non-competi-
tive control condition, both  RASV12 and  RASV12 (CMTPX) cells showed lower frequency of SYTOX blue staining 
with no significant difference between them (Fig. 1d).
Next, we evaluated the effects of co-culture on the growth rate of cells. The changes in  RASV12 cell numbers 
over time were compared between competitive and non-competitive co-cultures. We found competitive co-cul-
tures showed reduction in  RASV12 cell numbers after 24 h compared to  RASV12 (CMTPX) in the non-competitive 
condition (Fig. 1e). We then recorded the phenomenon occurring in the competitive co-culture. Time-lapse 
video revealed that  RASV12 cells surrounded by normal HypoE-N1 cells showed morphological changes involv-
ing rounding-up and eventually fragmentation (Fig. 1f, Supplementary Video S1). Collectively, our data suggest 
introduction of a small number of  RASV12 cells induced heterogeneity to the neuroepithelium and this established 
a model for cell competition with the loser  RASV12 cells being eliminated through non-cell autonomous cell death.
Neuroepithelial cell competition occurs by non-cell autonomous induction of apoptosis. We 
next investigated the mechanism of  RASV12 cell death from competitive co-culture. During cell competition, 
most of the loser cells will be eliminated by  apoptosis30. Thus, we asked whether  RASV12 cells in competitive co-
culture were also eliminated by apoptosis. Immunostaining with apoptosis markers active caspase-3 and cleaved 
PARP displayed positive signals in  RASV12 cells surrounded by normal cells in the competitive co-cultures. By 
contrast,  RASV12 (CMTPX) cells in non-competitive co-cultures did not show positive signals for either apopto-
sis marker (Fig. 2a,c). Quantification for active caspase-3 and cleaved PARP-positive signals showed  RASV12 cells 
were significantly higher compared to normal cells in the competitive condition (Fig. 2b,d).
During apoptosis, cytochrome-c is released from  mitochondria31. Healthy cells displayed punctate patterns 
of cytochrome-c staining that co-localized with mitochondria. In contrast, cells undergoing apoptosis showed a 
diffuse pattern of cytochrome-c.  RASV12 cells surrounded by normal cells in competitive co-culture displayed dif-
fuse cytochrome-c staining that did not co-localize with mitochondria (Fig. 2e). We next tried to block apoptosis 
by using the apoptosis inhibitor ZVAD in the co-cultures. ZVAD treatment significantly increased the number 
of  RASV12 cells in the competitive co-culture compared to those without ZVAD treatment (Fig. 2f).
A previous study reported involvement of the p38 MAPK pathway during cell  competition32. Immunofluo-
rescence staining for phospho-p38 in the competitive condition indicated p38 was activated in  RASV12 cells 
(Supplementary Fig. S2). To answer whether apoptosis was induced through the MAPK pathway, we inhibited 
p38 activation in the competitive co-cultures. The percentage of SYTOX blue positive cells was significantly lower 
in the presence of p38 inhibitor (Fig. 2g). These results indicated that  RASV12 cells in competitive co-culture 
underwent cell death through non-cell autonomous apoptosis.
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Figure 1.  Establishment of the neuroepithelial cell competition model. (a) Experimental scheme for 
neuroepithelial cell competition. In non-competitive control condition, EGFP-expressing  RASV12 cells were 
co-cultured with  RASV12 labeled with CMTPX. In competitive condition, normal (wild type) cells were 
co-cultured with EGFP-RASV12. The ratio of co-cultured cells for both conditions were 100:1. (b) Western 
blot analysis showing  RASV12 expression upon doxycycline induction. Gapdh was used as a loading control. 
(c) Representative images of SYTOX blue staining in non-competitive and competitive condition. Arrows 
indicate cells positive for SYTOX blue. Scale bars = 50 µm. (d) Frequency of SYTOX blue-positive cells in 
non-competitive and competitive condition. (e) Number of  RASV12 (CMTPX) in non-competitive and  RASV12 
(EGFP) cells in competitive condition at 0, 24, 48 and 72 h. (f) Snapshot images of time-lapse movie showing 
elimination of  RASV12 cell surrounded by normal cells through cell death induction. Scale bar = 20 µm. Data are 
shown as mean ± SEM from three independent experiments. (Student’s t-test *p < 0.05, **p < 0.01, ***p < 0.001).
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Figure 2.  Neuroepithelial cell competition occurs by non-cell autonomous induction of apoptosis. (a) 
Representative images of caspase-3 in  RASV12 cells in non-competitive and competitive condition. Arrows 
indicate cells positive for caspase-3. Scale bars = 50 µm. (b) Frequency of caspase-3 positive cells in non-
competitive and competitive condition. (c) Representative image of cleaved PARP in  RASV12 cells in non-
competitive and competitive condition. Arrows indicate positive for cleaved PARP. Scale bars = 50 µm. (d) 
Frequency of cleaved PARP positive cells in non-competitive and competitive condition. (e) Cytochrome-c and 
Mitotracker CMXROS staining in competitive condition showed cytochrome-c was diffusely stained in addition 
to co-localization with mitochondria in  RASV12 cell surrounded by normal cells. Scale bar = 50 µm. (f) Number 
of  RASV12 cells per field in competitive condition in the absence and presence of apoptosis inhibitor ZVAD. 
(g) Frequency of cell death indicated by SYTOX blue positivity in the competitive condition in the absence 
and presence of p38 inhibitor SB203580. Data are shown as mean ± SEM from three independent experiments 
(Student’s t-test *p < 0.05, **p < 0.01, ***p < 0.001).
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petitive condition. First, we investigated protein expression of JAGs in cells by immunofluorescence analysis. 
We observed as early as 16 h of competitive condition, Srsf7 expression was lost in  RASV12 cells surrounded 
by normal cells (Fig. 3a). In the non-competitive condition, the percentage of Srsf7 positivity among  RASV12 
and  RASV12 (CMTPX) cells was not significantly different, but in competitive co-cultures, the percentage of 
Srsf7 positive cells was significantly decreased in  RASV12 cells compared to normal cells (Fig. 3b). Western blot 
analysis of non-competitive condition cells showed Srsf7 expression was slightly reduced with  RASV12 induc-
tion (Fig. 3c). These results suggest competitive co-culture caused acute loss of Srsf7 in  RASV12 cells. We next 
explored how Srsf7 loss was faster in  RASV12 cells during the competitive condition. SR proteins have been 
reported to undergo post-translational modifications by phosphorylation, acetylation, methylation, ubiquityla-
tion and  sumoylation33. A previous study reported that SRSF5, one of the SR family members, was ubiquitylated 
by Smurf1 and undergoes proteasome-mediated  degradation34. To assess whether Srsf7 is degraded through the 
ubiquitin-proteasome pathway, we conducted ubiquitylation assays. We found that the ubiquitin immunoreac-
tive smear was significantly enhanced with MG132 treatment in HA-Ub transfected cells (Fig. 3d). To further 
analyze the loss of Srsf7 by proteasome-mediated degradation in the competitive condition, we treated the co-
cultures with MG132 and quantified the number of Srsf7 positive in  RASV12 cells in the absence and presence of 
MG132 (Fig. 3e). The percentage of Srsf7 positive in  RASV12 cells with MG132 treatment was higher compared to 
the non-treated group (Fig. 3f). These observations indicated that during competitive co-culture, Srsf7 in  RASV12 
cells was degraded through the ubiquitin-proteasome pathway. To investigate if restoring Srsf7 expression is 
sufficient to prevent  RASV12 cell elimination, we overexpressed Srsf7 in  RASV12 cells and co-cultured them with 
normal cells. Srsf7 overexpression in  RASV12 cells (HA-Srsf7) significantly increased the number of  RASV12 cells 
compared to control treatment (TdTomato, Fig. 3g). In addition, Srsf7 overexpression in  RASV12 cells (HA-Srsf7) 
significantly reduced the frequency of caspase-3 positive cells (Fig. 3h), which verifies that Srsf7 antagonizes the 
execution of cell competition. Collectively, these results revealed cell competition triggers the acute loss of Srsf7 
in  RASV12 cells through proteasome-mediated degradation.
Loss of Srsf7 suppresses Ezh2 expression in the loser cells. To investigate how the expression of 
other proteins change, we measured other JAGs protein expression after 24 h of co-culture. Competitive co-
cultures displayed acute loss of Ezh2 in  RASV12 cells (Fig. 4a). The percentage of Ezh2-expressing  RASV12 cells 
in competitive condition was significantly lower compared to normal cells (Fig. 4b). This observation showed 
a similar pattern with Srsf7 expression in non-competitive and competitive condition. Western blot analysis 
revealed Ezh2 expression in non-competitive condition was slightly downregulated with  RASV12 induction up to 
72 h (Fig. 4c). Next, we did immunofluorescence staining analysis for cytochrome-c to investigate whether Ezh2 
loser cells underwent apoptosis. We found that both Ezh2 positive and negative  RASV12 cells showed punctate 
staining, which suggests that Ezh2 loss occurs before apoptosis induction (Fig. 4d). Thus, our analyses revealed 
Srsf7 loss induced Ezh2 suppression in loser cells and was a primary mechanism in neuroepithelial cell competi-
tion.
Srsf7 depletion induces loss of cellular juvenescence through Ezh2. To elucidate the role of Srsf7 
in cell competition, we depleted Srsf7 in HypoE-N1 cells using gene-specific siRNA transfection. Knockdown 
efficiency was validated with quantitative PCR analysis (Fig.  5a). Srsf7 depletion significantly impaired cell 
growth (Fig. 5b,c). We had previously identified Srsf7 and Ezh2 as  JAGs27. Ezh2 mRNA expression was down-
regulated upon Srsf7 knockdown (Fig. 5d), which suggests Srsf7 regulates Ezh2 transcription. Immunostaining 
showed Ezh2 expression was markedly reduced in Srsf7-depleted cells (Fig. 5e). This finding was corroborated by 
western blot analysis which showed Ezh2 (one of the JAGs) protein levels were suppressed in the Srsf7-depleted 
cells, while the expression of gamma H2AX (senescence-associated protein) was increased (Fig. 5f). To analyze 
how cellular juvenescence was regulated by Ezh2, we tested the consequences of Ezh2 depletion on HypoE-N1 
cells. siRNA-mediated knockdown of Ezh2 led to increased expression of senescence-associated proteins P16 
and gamma H2AX (Fig. 5g). To further test whether Srsf7 suppression was sufficient to induce cell competition, 
we co-cultured Srsf7-knocked down in normal HypoE-N1 cells with normal HypoE-N1 cells. We found the 
number of Srsf7-knocked down cells was reduced compared to control siRNA transfected cells. Furthermore, 
we observed a significant increase of caspase-3 positive in Srsf7-knocked down cells (Supplementary Fig. S3). 
These findings indicate Srsf7 depletion in loser  RASV12 cells induces loss of cellular juvenescence through Ezh2 
suppression and is sufficient to induce cell competition.
Neuroepithelial cell competition removes loser cell corpora via phagocytosis. The phagocytic 
elimination of cells undergoing apoptosis is a conserved mechanism among multicellular organisms. Defects in 
phagocytosis processes can lead to structural and functional errors in morphogenesis and tissue  homeostasis35. 
We therefore sought to identify the removal of apoptosis-undergoing  RASV12 cells in the competitive co-culture. 
In competitive co-culture, we found  RASV12 cells had been engulfed by normal cells (Fig. 6a). To confirm that 
 RASV12 cells were phagocytized by normal cells, we labeled the phagosome with CD68 antibody. We found 
 RASV12 cells were co-localized with CD68 in normal cells which suggested active phagocytosis (Fig. 6b). Next, 
we quantified phagocytosis by counting co-localization of  RASV12 cells with CD68, and our results showed 
phagocytosis was being promoted in competitive co-culture (Fig. 6c). To demonstrate that HypoE-N1 cells pos-
sess phagocytic capacity, we used a FITC-dextran assay and a phagocytosis assay of cells induced to undergo 
apoptosis by ultraviolet (UV) exposure. In the cells incubated with FITC-dextran, we observed uptake of FITC-
dextran into the cells by positive green signals (Fig. 6d). Flow-cytometric analysis of cells incubated with FITC-
dextran at 37 °C showed positive signal (Fig. 6e,f). In the phagocytosis assay, cultures of HypoE-N1 cells were 
stained with red-conjugated phalloidin, a cytoskeletal marker, before co-incubating with UV-induced apop-
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Figure 3.  Neuroepithelial cell competition triggers Srsf7 loss in  RASV12 cells via proteasome-mediated 
degradation. (a) Representative images of Srsf7 expression in non-competitive and competitive condition. 
Arrows indicate Srsf7 loss in cells. Scale bars = 10 µm. (b) Frequency of Srsf7 positive cells in non-competitive 
and competitive condition. (c) Western blot analysis of Srsf7 expression in the non-competitive condition 
upon doxycycline induction. Gapdh was used as a loading control. (d) Ubiquitylation assay of Srsf7. Cells 
were transfected with HA-tagged ubiquitin and treated with MG132, 5 µM for 8 h before lysate collection. 
The ubiquitylation of Srsf7 was determined by IP-western. Note that samples were derived from the same 
experiment and blots were processed in parallel. Full length blots are presented in Supplementary Fig. S4. (e) 
Representative images of Srsf7 expression in the absence and presence of proteasome inhibitor MG132 during 
competitive condition. Arrows indicate Srsf7 positive cells. Scale bars = 20 µm. (f) Frequency of Srsf7 positive 
cells in the absence and presence of proteasome inhibitor MG132 during competitive condition. (g) Number 
of  RASV12 cells counted after 24 h in the competitive condition of normal cells with control TdTomato  RASV12 
cells or HA-Srsf7 overexpressed  RASV12 cells. (h) Frequency of caspase-3 positive in control TdTomato  RASV12 
cells or HA-Srsf7 overexpressed  RASV12 cells during competitive condition. Data are shown as mean ± SEM from 
three independent experiments (Student’s t-test **p < 0.01, ***p < 0.001).
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totic  RASV12 cells. Confocal microscopy showed cytoplasmic localization of  RASV12 in normal HypoE-N1 cells 
(Fig. 6g). Analyses of z-stack images revealed that  RASV12 cells were phagocytized by normal HypoE-N1 cells, 
and orthogonal projection view confirmed that  RASV12 apoptotic cells were internalized (Fig. 6h). These obser-
vations indicate HypoE-N1 cells have phagocytic capacity, and they can remove apoptotic  RASV12 cells from 
competitive co-culture through phagocytosis.
Discussion
Cell competition is an emerging field for developmental biology. The mechanistic relevance of cell competition 
addresses unresolved questions during development, for example, organ size and quality control mechanisms 
to eliminate unfit  cells36. Despite increasing numbers of cell competition models for development in different 
organs, there had not been a valid model for cell competition in developing brain. Findings of endogenous 
cell competition occurring in vivo during epiblast  formation1,37 had prompted us to investigate the role of cell 
competition in early brain development. Previous studies demonstrated cell competition in cell lines grown under 
routine culture conditions, and these have been used as in vitro models with different cell strains including human 
osteosarcoma  U2OS14, canine epithelial  MDCK20 and embryonic fibroblasts  NIH3T338. By utilizing HypoE-N1, 
a neural progenitor cells (NPCs) line, we established an in vitro model system for cell competition in the brain 
and explored the molecular mechanisms for loser cell elimination.
During brain development, mitotic events and environmental insults lead to somatic mutations which can 
produce suboptimal cells that can compromise tissue integrity. Competitive interactions between cells have clear 









































































Figure 4.  Loss of Srsf7 induces Ezh2 suppression in the loser cells. (a) Representative images of Ezh2 
expression in non-competitive and competitive condition. Arrows indicate Ezh2 loss in cells. Scale bars = 20 µm. 
(b) Frequency of Ezh2 positive cells in non-competitive and competitive condition. (c) Western blot analysis of 
Ezh2 expression in the non-competitive condition upon doxycycline induction. Tubulin was used as a loading 
control. (d) Cytochrome-c staining showed punctate pattern in both  RASV12 cells with Ezh2 positive and Ezh2 
negative cell. Scale bars = 20 µm. Data are shown as mean ± SEM from three independent experiments (Student’s 
t-test ***p < 0.001).
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Figure 5.  Srsf7 suppression induces loss of cellular juvenescence. (a) qPCR analysis of Srsf7 knockdown 
efficiency in HypoE-N1 cells after 48 h transfection of control siRNA, Srsf7 siRNA1 or siRNA2. (b) Number 
of cells per field 72 h after transfection with control siRNA or Srsf7 siRNA1 and siRNA2. (c) Appearance of 
HypoE-N1 cells after transfection with control siRNA or Srsf7 siRNA 1 and siRNA 2. Scale bars = 50 µm. (d) 
qPCR analysis of Ezh2 mRNA expression 72 h after transfection with control siRNA, Srsf7 siRNA1 or siRNA2. 
(e) Immunofluorescent staining of Ezh2 in HypoE-N1 cells 48 h after transfection with control siRNA or Srsf7 
siRNA. Scale bars = 20 µm. (f) Western blot analysis with HypoE-N1 cells 72 h after transfection with control 
siRNA or Srsf7 siRNA. Tubulin was used a loading control. (g) Western blot analysis with HypoE-N1 cells 72 h 
after transfection with control siRNA or Ezh2 siRNA. Tubulin was used a loading control. Data are shown as 
mean ± SEM from three independent experiments (Student’s t-test **p < 0.01, ***p < 0.001).
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discovered to be activated in glioblastoma multiforme in  adults41. We proposed that cell competition act as a 
quality control mechanism in the developing brain to ensure proper tissue growth and homeostasis maintenance. 
Studies have reported the potential role of cell competition to eliminate RasV12-transformed cells from epithelia 
through cell death or apical  extrusion20,42. RasV12-transformed cells in epithelia trigger non-cell autonomous 
changes in both types of  cells43. In this study, we found  RASV12 cells demonstrated loss of cellular juvenescence 
which resulted in the important selective elimination of  RASV12 cells through a non-cell autonomous manner. 
This mechanism of cell competition maintains tissue integrity and acts as quality control by ensuring that cells 
with deleterious mutations such as  RASV12 are eliminated from neuroepithelia during brain development.
Our results showed that introduction of heterogeneity by induction of  RASV12 in a small proportion of the 
cells caused cell competition. Previous studies reported that elimination of loser cells during cell competition was 
through  apoptosis14,17,19 with the removal of apoptotic loser cells by  phagocytosis17. These reports supported our 
data, which showed that in competitive condition,  RASV12 cells were recognized by the surrounding normal cells 
and eliminated by non-cell autonomous induction of apoptosis followed by phagocytosis by the neighbouring 
winner cells. Neural progenitor cells are known to be phagocytes, and their phagocytic activity can regulate 
adult  neurogenesis44.
We showed in this study that the elimination of  RASV12 cells was context-dependent. This was evidenced 
with our finding in non-competitive condition of  RASV12 to  RASV12 (CMTPX) co-culture that apoptosis was 
not observed. Furthermore, we demonstrated neuroepithelial cell competition requires cell–cell contact and was 
not mediated by soluble factors. Thus, the apoptosis observed in  RASV12 cells was the result of cell competition 
in a non-cell autonomous manner. Currently, the molecular mechanism underlying loser cells elimination is 
unresolved. In Drosophila, expression of Flower gene can distinguish loser cells from winner cells by alternative 
splicing of the FweLose-A/B isoforms in loser cells. This isoform is necessary and sufficient for competition-
driven cell  elimination15. Myc-driven cell competition in mouse epiblast demonstrated BMP signalling was 
decreased in loser  cells1. Our study revealed for the first time that during neuroepithelial cell competition, acute 
loss of Srsf7 and Ezh2 in loser cells preceded their elimination. We hypothesized that the presence of senescent 
cells in the early developing brain was related to apoptosis, which has been widely reported. Our findings provide 
evidence that during early brain development the presence of senescent cells losing cellular juvenescence might 
activate cell competition resulting in cellular discrimination and removal from the neuroepithelia by apoptosis.
Proteasome regulation of the SR protein family is less understood. We hypothesized that the acute loss of Srsf7 
in competitive condition observed in this study was linked to ubiquitylation and proteasome degradation. Our 
results suggested that Srsf7 underwent degradation via the ubiquitin-proteasome pathway. Besides the known 
function of Srsf7 as a splicing factor, SR proteins have also been identified as regulators of gene  expression33. 
Through functional analyses of Srsf7, we demonstrated that it was indispensable for cell growth and survival. Srsf7 
suppression induced loss of cellular juvenescence through Ezh2 suppression at both mRNA and protein levels. 
The loss of cellular juvenescence was further evidenced with enhancement of senescence-associated proteins 
P16 and gamma H2AX. Ezh2 suppression has been reported to rapidly elicit DNA damage and trigger the onset 
of senescence without loss of  H3K27me345. Akizu et al. reported that Ezh2 is required for neural progenitor 
proliferation and has been linked to a number of human diseases including some neurodegenerative  disease46.
In summary, we have uncovered how cell competition as a quality control mechanism might maintain 
brain homeostasis. Mechanistically, cellular juvenescence in unwanted loser cells is deregulated during brain 
development. Further studies should determine whether this molecular mechanism was conserved in other 
mammalian tissues. The potential of Srsf7 and other JAGs to be drug targets should also be investigated. Cell 
competition could be exploited to conceive novel therapeutic interventions in neurological diseases that may 
boost elimination of unwanted and damaged cells.
Methods
Antibodies and materials. The following antibodies were used in this study; Srsf7 (Thermo Fisher Scien-
tific, PA5-39482), Ezh2 (Cell Signaling Technology, #5246S), P16 ARC (Abcam, ab51243), γH2AX (Cell Signal-
ing Technology, #9718), RAS (Cell Signaling,#3965S), HA (Abcam, Ab9110), Gapdh (Cell Signaling Technology, 
#5174), alpha/beta tubulin (Cell signaling Technology, #2148S), Rabbit IgG (Cell Signaling, #3900), active cas-
pase 3 (Abcam, Ab2302), cleaved PARP (Cell Signaling Technology, #9544), CD68 (abcam,ab955), cytochrome-
C (Santa-cruz,sc-13156), cleaved caspase 3 (Cell Signaling, #9661S) and phospho-p38 (Cell Signaling, #4511S). 
Phalloidin conjugated-TRITC (Sigma-Aldrich, P1951) was used at 50 µg/ml. Celltracker Green CMFDA dye 
and Red CMTPX dye (Life Technologies) were used at 10 µM to label the cells. Mitotracker CMXRos (Ther-
mofisher) was used at 100 nM.
Generation of inducible  RASV12-EGFP in HypoE-N1 cells. HypoE-N1 (Cedarlane, #CLU101), a neu-
ral progenitor cell line (NPCs) derived from mouse hypothalamus was used in this study. HypoE-N1 cells were 
cultured in Dulbecco’s modified Eagle’s medium containing 10% fetal bovine serum. HypoE-N1 cells that express 
doxycycline-inducible  RASV12-EGFP were established by serial transfection of pcDNA6/TR and pcDNA4/TO-
RASV12-EGFP. The plasmids were gifts from Shunsuke Kon and Yasuyuki Fujita (Hokkaido University, Japan). 
To induce  RASV12 expression, 20 µg/ml of doxycycline (LKT laboratories, Inc) was used.
Conditioned medium assay. Conditioned media (CM) from HypoE-N1 cells and competitive co-cul-
tures were centrifuged at 200 g for 3 min. Supernatants of CM were collected and then added to pre-cultured 
 RASV12 cells for 24 h. The  RASV12 cells had been pre-treated overnight with doxycycline before plating.
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Indirect co-culture assay. ThinCert cell culture membrane inserts for 12-well plates (Greiner bio-one, 
665641) were used to keep HypoE-N1 cells and  RASV12 cells separated by a membrane filter. 5 × 105 cells/ml per 
well were seeded in the lower plates  (RASV12 cells), and 2 × 105 cells/0.5 ml per well were seeded in the upper 
transwell insert (HypoE-N1 cells). Cells were pre-cultured overnight and then treated with doxycycline for 24 h.
Establishment of neuroepithelial cell competition model. For competitive co-culture, normal and 
 RASV12 were co-cultured at 100:1 ratio while for non-competitive condition,  RASV12 and  RASV12 labeled with 
CMTPX (red dye) were co-cultured at 100:1 ratio. Both co-culture conditions were established at > 95% con-
fluency and incubated overnight before doxycycline treatment to induce the expression of  RASV12-EGFP. We 
optimized the cell numbers plated in a 6-well plate to create a condition where  RASV12 cells were surrounded 
by normal cells (competitive condition), and  RASV12 (CMTPX) cells were surrounded by  RASV12 cells (non-
competitive condition).
RNAi-mediated knockdown and overexpression. In knockdown experiments, Lipofectamine 
RNAiMAX (Invitrogen) was used to transfect the siRNA duplexes at 50  nM: mouse Srsf7 siRNA1 (Bioneer, 
AccuTarget siRNA ID142429), siRNA2 (Sigma-Aldrich, siRNA ID SASI_Mm01_00138329.ID1424259), mouse 
Ezh2 (Bioneer, AccuTarget siRNA ID 1356125) and siRNA negative control (Applied Biosystems, AM4611). 
After 48 h, qPCR or western blot analysis were carried out to assess knockdown efficiency. For overexpression 
experiments, Lipofectamine 2000 (Invitrogen) was used according to the manufacturer’s instruction to transfect 
plasmid pcDNA-TO-HA-Srsf7 or control pcDNA3.1-TdTomato into HypoE-N1 cells. The images of live cells 
were captured using an EVOS FL microscope (Thermo Fisher Scientific). For the purpose of cell growth analysis, 
numbers of cells per field were counted manually.
Immunofluorescence staining. Co-culture cells were plated on glass cover slips. The mixture of cells was 
incubated overnight, followed by doxycycline treatment for 24–72 h. Cells were fixed in 4% paraformaldehyde 
(PFA) for 10 min at RT, permeabilized with 0.1% Triton X-100 for 2 min at RT, blocked with 2% FBS for 1 h, 
and incubated with primary antibodies at 4 °C overnight. After three 10-min washes in PBS, cells were incu-
bated with secondary antibodies (anti-rabbit-IgG conjugated to Alexa-546 [Invitrogen, AQ17) or anti-mouse-
IgG conjugated to Alexa-647 (Invitrogen, A21235)] at 1:1,000 for 1 h at RT. After three 10-min washes in PBS, 
coverslips with cells were mounted onto Prolong Gold DAPI (Invitrogen, P36971) on a glass slide. Images were 
captured by Olympus FV1000 or Leica, TCS SP8 confocal microscopes. ImageJ software was used for image 
analysis. Positive and negative cells were defined based on fluorescence intensity. Signals in negative controls 
were set as threshold and cells with fluorescence intensity higher than threshold were considered positive.
SYTOX blue. Cells were seeded in 6-well plates and induced with 20 µg/ml of doxycycline for 24 h. Culture 
media were then removed and replaced with media containing 5 nM SYTOX blue. Cells were incubated with 
SYTOX blue at 37 °C for 30 min in 5%  CO2 incubator. After incubation, the SYTOX Blue solution was removed 
and cell images captured using an EVOS fluorescence microscope. Numbers of SYTOX blue positive cells were 
counted in 10 areas and averaged.
Apoptosis assay. Dead cells that had undergone apoptosis were analyzed after 24 h doxycycline induction 
by immunofluorescence staining for active caspase-3 and cleaved PARP. Positive cells were counted on five inde-
pendent 40X fields for each sample and averaged.
Time-lapse microscopy. Cells were co-cultured on glass-bottom culture dishes (Mat-Tek Corporation) 
and allowed to attach for 16 h before addition of doxycycline. After 8 h of doxycycline induction, cells were 
recorded at 10 min/frame interval for 24 h using an Olympus IX83 microscope. Cells were maintained at 37 °C, 
5%  CO2 and 100% humidity during recording. Videos were analyzed by an Olympus CellSens software and 
processed with Adobe Photoshop and Image J.
Figure 6.  Neuroepithelial cell competition removes loser cell corpora via phagocytosis. (a) Representative 
image of  RASV12 cell corpora phagocytized by surrounding normal HypoE-N1 cell. Arrows indicate  RASV12 
cells corpora. Scale bar = 10 µm. (b) Representative image of co-localization  RASV12 cell corpora with CD68 
(phagosome marker), depicted by arrows. Scale bar = 5 µm. (c) Percentage of phagocytosis at 48 h, counted from 
co-localization of CD68 and  RASV12 cell corpora. (d) FITC-dextran uptake assay. HypoE-N1 cells were plated 
one day before and then exposed to 1 mg/ml FITC-dextran for 2.5 h at 37 °C and 4 °C (as negative control). 
Scale bars = 50 µm. (e) Flow cytometric analysis of FITC-dextran uptake in HypoE-N1 cells. HypoE-N1 cells 
incubated with FITC-dextran at 37 °C showed significant shift to the right quadrant. (f) The right-most open 
pink histogram represent HypoE-N1 cells incubated with FITC dextran at 37 °C , green histogram indicates 
HypoE-N1 cells incubated with FITC dextran at 4 °C and the filled purple histogram represent HypoE-N1 
cells only at 37 °C. (g) Representative image for phagocytosis of apoptotic cell by HypoE-N1 cells during 
phagocytosis assay after 5 h co-incubation of UV-induced apoptosis  RASV12 cells with HypoE-N1 cells at 10:1 
ratio. Scale bar = 20 µm. (h) Confocal z-stack image (orthogonal projection) for internalization of UV-induced 
apoptosis  RASV12 cells in HypoE-N1 cells. Scale bar = 5 µm. Data are shown as mean ± SEM from two 
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FITC dextran uptake assay. HypoE-N1 cells were incubated with FITC-conjugated dextran (1 mg/ml) 
(Tokyo Chemical Industry) at 37 °C, or at 4 °C (negative control) for 2 h in culture medium. After washing with 
PBS supplemented with 1% BSA, cells were prepared for flow cytometric analysis by centrifugation at 300–400 g 
for 5 min (RT). Cell pellets were then collected and resuspended in PBS/BSA, followed by centrifugation at 
300–400 g for 5 min (RT). Pellets were collected and diluted with PBS/BSA to 1 × 107 cells/ml or greater. The 
diluted cells were transferred into FACs tubes and analyzed by flow cytometry (FACSCalibur, BD Biosciences). 
HypoE-N1 cells positive for FITC fluorescent signal were considered as cells that had engulfed the dextran.
Phagocytosis assay. The phagocytosis assay was modified from Lu et al.44. Doxycycline (20 ug/ml) was 
added to HypoE-N1-RASV12-EGFP cell lines for 24 h to induce expression of EGFP-RASV12.  RASV12 cells were 
then dissociated and exposed to ultraviolet light for 15 min to induce apoptosis before incubating with pre-
plated HypoE-N1 cells for 4 h. Cells were then washed with cold PBS to stop phagocytosis, fixed in 4% PFA for 
10 min at RT, and stained with 50 µg/ml phalloidin-conjugated TRITC in PBS (Sigma-Aldrich, P1951, 30 min 
at RT) to identify actin. Nuclei were counterstained with Prolong Gold DAPI (Invitrogen, P36971) mounting 
agent. Images were visualized with an Olympus FV1000 laser confocal microscope under 100 × magnification 
and Z-stack images were generated with z-step size at 0.5 µm.
Quantitative RT-PCR. Total RNA was extracted with TRIzol reagent (Thermo Fisher Scientific). Extracted 
RNA was quantified using a NanoDrop Lite Spectrophotometer (Thermo Fisher Scientific), and reverse tran-
scribed with high-capacity RNA-to-cDNA kit (Applied Biosystems) using a PCR thermal cycler Dice (Takara) 
according to the manufacturer’s instructions. Synthesized cDNAs were amplified by qPCR using a LightCycler 
480 SYBR Green I Master Kit on a LightCycler 480 instrument (Roche). Quality and specificity of the qPCR 
amplification was determined by a melting curve analysis. Normalization was made to mouse Tubb5 or Polr2a. 
Primers used for the qPCR are listed in Supplementary Table S1.
In vivo ubiquitylation assay. To analyze Srsf7 ubiquitylation, HypoE-N1 cells were transfected with a 
HA-Ubiquitin expressing plasmid, kindly gifted by Toshifumi Morimura (Shiga University of Medical Science). 
Transfected cells were treated with 5 µM MG132 (Cell Signaling, #2194) for 8 h before cell harvest to enhance 
ubiquitylation signals. For immunoprecipitation, Dynabeads Protein A (Invitrogen) were incubated with 2 µg 
Srsf7 and rabbit IgG antibody for 1 h at RT, and then cell lysates were added to the antibody-bead complexes for a 
further 16 h at 4 °C. Beads were washed with lysis buffer three times followed by elution with 1X Laemmli sample 
buffer and denaturation at 70 °C for 10 min. The samples were separated in an 8% SDS-PAGE gel followed by 
western blotting with HA and Srsf7 antibodies.
Western blot. Proteins were extracted in RIPA lysis buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% 
NP-40, 1% sodium deoxycholate and 0.1% SDS). SDS-polyacrylamide gel electrophoresis (PAGE) was carried 
out by dissolving lysates in 5 × Laemmli sample buffer, boiling at 95 °C for 2 min, separation of protein samples 
(20 μg per lane) through 4–15% PAGE gels and transferring separated proteins to Hybond-P PVDF membrane 
(GE Healthcare). The membranes were incubated with primary antibodies at 4 °C (O/N), followed by appropri-
ate HRP conjugated anti-immunoglobulin antibodies (1 h/RT) (Thermo Fisher Scientific, anti-mouse 32,430 
and anti-rabbit 32,460 at 1:1000). The immunoreactive bands were detected using Chemi-Lumi One L, Chemi-
Lumi One Super or Chemi-Lumi One Ultra (Nacalai Tesque). Protein bands were visualized using Image Quant 
LAS 4000 digital imaging system. Uncropped membranes are illustrated in Supplementary Figure S4.
Statistical analyses. Statistical analyses were performed with Prism 5 statistical software (Graphpad) by 
using unpaired two-tailed Student’s t-tests. The mean ± SEM is presented for all quantified data and p values less 
than 0.05 were considered significant.
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